About Evitalife
Evitalife offers products and services including PCD Pharma Franchise and Third Party Manufacturing.
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Phone•••• ••••
- Social Facebook Instagram
- Legal Name Evitalife Pharma Pvt. Ltd
- Date of Incorporation 14 Jan, 2012
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹5.68 Cr
FY 2024 · -3% YoY
- Net Profit₹2.3 Lakh
FY 2024 · 0% margin
- EBITDA₹8.1 Lakh
FY 2024 · 1% margin
Associated legal entities of Evitalife
Evitalife operates through Evitalife Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Evitalife Pharma Private Limited CIN U24233DL2012PTC229963 | Active | 14 Jan 2012 | New Delhi, Delhi | ₹5.7 Cr | – | 2 | View details |
Products & Services of Evitalife
Evitalife offers a comprehensive portfolio of products and services, including PCD Pharma Franchise and Third Party Manufacturing.
PCD pharma franchise services are provided by Evitalife, offering monopoly-based opportunities and support for distribution across various therapeutic segments.
Third party manufacturing services are delivered by Evitalife, producing WHO-GMP-certified products in forms such as tablets, capsules, and syrups for partners.
Board of directors of Evitalife Pharma Private Limited (Evitalife)
Evitalife Pharma Private Limited is the primary company behind Evitalife. The board of Evitalife Pharma Private Limited currently have 2 directors; the longest-serving is Rohit Kumar Barnwal, appointed in 2012. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rohit Kumar Barnwal DIN 05157951 | Director | 14 Jan 2012 | 14 yrs 8 mo | Evitalife Pharma Private Limited |
| Subhash Kumar DIN 06959510 | Director | 13 Mar 2016 | 10 yrs 6 mo | Evitalife Pharma Private Limited |
Financials of Evitalife
Figures of Evitalife Pharma Private Limited, the primary company behind Evitalife, for FY 2024. Revenue was ₹5.68 Cr (-3% year on year). Net profit was ₹2.3 Lakh (0% margin). EBITDA was ₹8.1 Lakh (1% margin). Revenue has grown at a compounded annual rate of +36% over three years and +73% over five years.
- ₹5.68 CrRevenue · FY 2024 · -3% YoY
- ₹2.3 LakhNet profit · 0% margin
- ₹8.1 LakhEBITDA · 1% margin
- ₹20 LakhPaid-up capital
- +36%Revenue CAGR, 3 years
- +73%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Evitalife Pharma Private Limited are on its company page.
Detailed financial statements for Evitalife
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Evitalife
10 companies that operate in the same segment as Evitalife (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Evitalife
The primary company behind Evitalife, Evitalife Pharma Private Limited, reported revenue of ₹5.68 Cr for FY 2024, down 3% year on year.
Evitalife is recognized as a leading pharmaceutical company based in Baddi, Himachal Pradesh, where PCD pharma franchise and third-party manufacturing services are provided. A wide range of WHO-GMP-certified products across therapeutic segments is made available, empowering partners with monopoly opportunities and reliable production. Commitment to quality and customer success is demonstrated through support for over 1000 customers, ensuring accessible healthcare solutions are delivered efficiently.
Evitalife offers PCD Pharma Franchise and Third Party Manufacturing.
Evitalife operates through Evitalife Pharma Private Limited.
The legal entities of Evitalife currently have 2 directors, including Rohit Kumar Barnwal, Subhash Kumar.